Literature DB >> 14977868

In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.

Khawja A Usmani1, Edward D Karoly, Ernest Hodgson, Randy L Rose.   

Abstract

Cytochrome P450 (P450) and flavin-containing monooxygenase (FMO) enzymes are major catalysts involved in the metabolism of xenobiotics. The sulfoxidation of the thioether pesticides, phorate, disulfoton, sulprofos, and methiocarb, was investigated. Using pooled human liver microsomes (HLMs), thioether compounds displayed similar affinities; however, phorate and disulfoton displayed higher intrinsic clearance rates than either sulprofos or methiocarb. The sulfoxidation of thioethers by HLMs was found to be predominantly P450-driven (85-90%) compared with FMO (10-15%). Among 16 cDNA-expressed human P450 isoforms and 3 human FMO isoforms examined, the following isoforms and their polymorphisms had the highest rates for sulfoxidation, as follows: phorate, CYP1A2, 3A4, 2B6, 2C9*1, 2C18, 2C19, 2D6*1, and FMO1; disulfoton, CYP1A2, 3A4, 2B6, 2C9*1, 2C9*2, 2C18, 2C19, 2D6*1, and FMO1; sulprofos, CYP1A1, 1A2, 3A4, 2C9*1, 2C9*2, 2C9*3, 2C18, 2C19, 2D6*1, and FMO1; methiocarb, CYP1A1, 1A2, 3A4, 2B6, 2C9*1, 2C19, 2D6*1, and FMO1. Among these isoforms, members of the CYP2C subfamily often had the highest affinities and clearance rates. Moreover, sulfaphenazole, a CYP2C9 competitive inhibitor, inhibited disulfoton sulfoxidation by CYP2C9 (IC50 0.84 microM) as well as in HLMs. Ticlopidine, a CYP2C19 mechanism-based inhibitor, inhibited disulfoton sulfoxidation by CYP2C19 (IC50 after coincubation, 43.5 microM; IC50 after preincubation, 4.3 microM) and also in HLMs. Our results indicate that current models of the substrate binding site of the CYP2C subfamily would not effectively predict thioether pesticide metabolism. Thus, the substrate specificity of CYP2Cs is more extensive than is currently believed, and some reevaluation of structure-activity relationships may be required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977868     DOI: 10.1124/dmd.32.3.333

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazone.

Authors:  Rodolpho C Braga; Vinícius M Alves; Carlos A M Fraga; Eliezer J Barreiro; Valéria de Oliveira; Carolina H Andrade
Journal:  J Mol Model       Date:  2011-09-08       Impact factor: 1.810

2.  Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.

Authors:  Jun Yang; Melissa A VanAlstine; James G Phillips; Mark P Wentland; Lindsay B Hough
Journal:  Acta Pharm Sin B       Date:  2012-04       Impact factor: 11.413

3.  Hypersalinity acclimation increases the toxicity of the insecticide phorate in coho salmon (Oncorhynchus kisutch).

Authors:  Ramon Lavado; Lindley A Maryoung; Daniel Schlenk
Journal:  Environ Sci Technol       Date:  2011-04-13       Impact factor: 9.028

Review 4.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

5.  Computational-Based Mechanistic Study and Engineering of Cytochrome P450 MycG for Selective Oxidation of 16-Membered Macrolide Antibiotics.

Authors:  Song Yang; Matthew D DeMars; Jessica M Grandner; Noelle M Olson; Yojiro Anzai; David H Sherman; K N Houk
Journal:  J Am Chem Soc       Date:  2020-10-08       Impact factor: 15.419

6.  The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent.

Authors:  Gang Xie; Ka-Wing Cheng; Liqun Huang; Basil Rigas
Journal:  Biochem Pharmacol       Date:  2014-07-18       Impact factor: 5.858

7.  Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.

Authors:  Stella Koutros; Gabriella Andreotti; Sonja I Berndt; Kathryn Hughes Barry; Jay H Lubin; Jane A Hoppin; Freya Kamel; Dale P Sandler; Laurie A Burdette; Jeffrey Yuenger; Meredith Yeager; Michael C R Alavanja; Laura E Beane Freeman
Journal:  Pharmacogenet Genomics       Date:  2011-10       Impact factor: 2.089

8.  Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans.

Authors:  Pan Deng; Dafang Zhong; Kate Yu; Yifan Zhang; Ting Wang; Xiaoyan Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

9.  The human intestinal cytochrome P450 "pie".

Authors:  Mary F Paine; Heather L Hart; Shana S Ludington; Robert L Haining; Allan E Rettie; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2006-02-07       Impact factor: 3.922

10.  Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes.

Authors:  Susan Searles Nielsen; Roberta McKean-Cowdin; Federico M Farin; Elizabeth A Holly; Susan Preston-Martin; Beth A Mueller
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.